Literature DB >> 6313027

Blood monocyte aryl hydrocarbon hydroxylase activity in psoriasis.

G Mason, M D Rawlins, S Shuster.   

Abstract

The activity of aryl hydrocarbon hydroxylase (AHH) in monocytes from 13 healthy control subjects and in 16 patients with discoid psoriasis was measured. The mean basal monocyte AHH activities of the control and psoriatic groups were 3.4 +/- 0.47 and 4.46 +/- 0.55 respectively (pmol 3-OHBP h-1 10(-6) cells). This difference was not significant. The mean induced monocyte AHH activities in the control and psoriatic groups were 56.4 +/- 10.8 and 77.8 +/- 16.0 pmol 3-OHBP h-1 10(-6) cells respectively but this difference was not significant. The mean induction ratios in the control and psoriatic groups were 16.5 +/- 1.8 and 20.4 +/- 3.6 respectively. Again, this difference was not significant. We conclude therefore, that monocyte aryl hydrocarbon hydroxylase activity is not reduced in psoriasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313027      PMCID: PMC1428007          DOI: 10.1111/j.1365-2125.1983.tb02170.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Development of an assay for aryl hydrocarbon (benzo(a)pyrene) hydroxylase in human peripheral blood monocytes.

Authors:  R C Bast; T Okuda; E Plotkin; R Tarone; H J Rapp; H V Gelboin
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

2.  Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme.

Authors:  D W Nebert; H V Gelboin
Journal:  J Biol Chem       Date:  1968-12-10       Impact factor: 5.157

3.  Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes.

Authors:  G Kellermann; M Luyten-Kellermann; C R Shaw
Journal:  Am J Hum Genet       Date:  1973-05       Impact factor: 11.025

4.  The dangerous alcoholic.

Authors:  C Brewer; W J Smith
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

5.  Arylhydrocarbon hydroxylase activity in lymphocytes of patients with psoriasis.

Authors:  T Ruzicka; W Vizethum; A Jacobs; G Goerz
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

6.  Aryl hydrocarbon hydroxylase activity and psoriasis.

Authors:  M J Finnen; S Shuster; C M Lawrence; M D Rawlins
Journal:  Biochem Pharmacol       Date:  1983-06-01       Impact factor: 5.858

7.  Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis.

Authors:  P H Chapman; P J Kersey; B Keys; S Shuster; M D Rawlins
Journal:  Br Med J       Date:  1980-11-15

8.  Activity of aryl hydrocarbon hydroxylase in psoriatic skin.

Authors:  P H Chapman; M D Rawlins; S Shuster
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

9.  Aryl hydrocarbon hydroxylase activity in cultured lymphocytes of psoriatic patients.

Authors:  N T Kärki; J Karvonen; O Pelkonen
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

  9 in total
  1 in total

1.  Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; L Linzmayer; H V Semlitsch; P Anderer; K Chwatal
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.